Achilles Therapeutics (ACHL)
NASDAQ: ACHL
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM
Achilles Therapeutics Revenue
Achilles Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2024, Achilles Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
204
Market Cap
60.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|